Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal.
Saved in:
| Title: | Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal. |
|---|---|
| Authors: | Ziegler D; Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany. dan.ziegler@ddz.de., Kempler P; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Bala C; Department of Diabetes and Nutrition Diseases, ''Iuliu Hatieganu'' University of Medicine and Pharmacy, Cluj-Napoca-Napoca, Romania., Mankovsky B; Shupyk National Healthcare University of Ukraine, Kiev, Ukraine., Schnell O; Forschergruppe Diabetes E.V., Helmholtz Munich (Helmholtz Zentrum München), Neuherberg (Munich), Neuherberg,, Germany., Spallone V; Department of Systems Medicine, Endocrinology Section, University of Rome Tor Vergata, Rome, Italy., Stirban A; Asklepios Klinik Birkenwerder, Heinrich Heine University, Birkenwerder, Düsseldorf, Germany., Tesfaye S; Diabetes Research Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. |
| Source: | Diabetology & metabolic syndrome [Diabetol Metab Syndr] 2026 Jul 30; Vol. 18 (1). Date of Electronic Publication: 2026 Jul 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101488958 Publication Model: Electronic Cited Medium: Print ISSN: 1758-5996 (Print) Linking ISSN: 17585996 NLM ISO Abbreviation: Diabetol Metab Syndr Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
